SCHEIN PHARMACEUTICAL
Schein Pharmaceutical believes it is one of the leading generic pharmaceutical companies in terms of United States revenues. The Company develops, manufactures and markets one of the broadest generic product lines in the pharmaceutical industry through the integration of its product development expertise, diverse, high-volume production capacity and direct sales and marketing forces.
SCHEIN PHARMACEUTICAL
Industry:
Biotechnology Health Care Manufacturing Pharmaceutical
Founded:
1994-01-01
Address:
Florham Park, New Jersey, United States
Country:
United States
Status:
Active
Similar Organizations
Chartwell Pharmaceuticals
Chartwell Pharmaceuticals is a full-service manufacturing & packaging services firm that specializes in the pharmaceuticals sector.
Cohesive Technologies
Cohesive Technologies Inc. designs, manufactures, and markets breakthrough liquid chromatography (LC) solutions for the drug discovery.
Morton Grove Pharmaceuticals
Morton Grove Pharmaceuticals develops, manufactures, and markets topical liquid pharmaceuticals.
ODAN
Odan that develops, manufactures, markets, and sells products in different therapeutic categories.
Shenzhen Yuanxing Biopharmaceutical
Shenzhen Yuanxing Pharmaceutical develops, manufactures, and markets single used wound care and antibacterial products.
Zhuhai Rundu Pharmaceutical
Zhuhai Rundu Pharmaceutical manufactures and distributes pharmaceuticals.
Current Employees Featured
Stock Details
More informations about "Schein Pharmaceutical"
Henry Schein - Wikipedia
Henry Schein, Inc. is an American distributor of health care products and services with a presence in 33 countries. [4][5] Ethisphere named Henry Schein as one of the 2024 World's Most Ethical …See details»
Dental Supplies, Medical Supplies and Veterinary ... - Henry Schein
Henry Schein is a worldwide distributor of medical, dental and veterinary supplies including vaccines, pharmaceutical products, financial services and equipment.See details»
Schein Pharmaceutical 2025 Company Profile: Valuation, Investors ...
Information on acquisition, funding, investors, and executives for Schein Pharmaceutical. Use the PitchBook Platform to explore the full profile.See details»
Henry Schein, Inc. -- Company History
In 1992 Schein Holdings, Inc., the parent of Henry Schein, Inc. and Schein Pharmaceutical, spun off the latter as an independent company. By this time Schein was being run by Bergman, who …See details»
Schein Pharmaceutical - Crunchbase Company Profile …
Schein Pharmaceutical develops, manufactures, and markets generic product lines in the pharmaceutical industry.See details»
Our History - Henry Schein
Since Henry Schein opened his pharmacy in Queens, New York in 1932, our organization has become a Fortune 500® Company and the largest provider of health care products and …See details»
Schein Pharmaceutical International Inc - Company Profile and News
Company profile page for Schein Pharmaceutical International Inc including stock price, company news, executives, board members, and contact informationSee details»
Longtime Henry Schein CEO to Retire at End of 2025
5 hours ago Under Bergman, Henry Schein went from a small, U.S.-based dental mail order company to become what the company describes as the largest global full service dental …See details»
Henry Schein, Inc. - Company Profile, Information, Business …
In 1992 Schein Holdings, Inc., the parent of Henry Schein, Inc. and Schein Pharmaceutical, spun off the latter as an independent company. By this time Schein was being run by Bergman, who …See details»
Watson to acquire Schein Pharmaceutical in deal worth $674 million
May 25, 2000 Watson Pharmaceuticals has announced plans to buy its generics rivalSchein Pharmaceutical in a two-step transaction valued at $674 million and which will create a …See details»
Wholesale Pharmaceutical Distribution Solutions | Henry Schein
At Henry Schein, we are committed to advancing health care by providing innovative pharmaceutical solutions for some of the most prevalent and challenging disease states. As a …See details»
Henry Schein: Business Model, SWOT Analysis, and ... - PitchGrade
May 7, 2024 Henry Schein: Business Model, SWOT Analysis, and Competitors 2024 Introduction Henry Schein, Inc., founded in 1932, is a global leader in providing healthcare …See details»
Henry Schein, Inc. - Encyclopedia.com
May 18, 2018 Sales under the Henry Schein private label (manufactured by third parties or affiliated HS Pharmaceutical, Inc.) accounted for 8.6 percent of the total. The company ’ s total …See details»
BioPharmaLink profile of Schein Pharmaceutical, Inc., United States …
Schein Pharmaceutical, Inc. Schein Pharmaceutical, Inc. is a leader in the development, manufacturing and marketing of generic pharmaceutical products with a strong commitment to …See details»
Henry Schein History: Founding, Timeline, and Milestones - Zippia
Jul 21, 2023 Henry Schein was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.“ Since Henry Schein opened his pharmacy in Queens, New …See details»
Henry Schein, Inc. (HSIC): history, ownership, mission, how it works ...
This approach influences strategic decisions and operational priorities throughout the global organization. Henry Schein, Inc. (HSIC) How It Works Henry Schein operates primarily as a …See details»
Pharmaceuticals – Supplies Reference Guide - Henry Schein
The pharmaceuticals section of our source catalog is an excellent brand and generic equivalent reference guide. Along with the leading pharmaceuticals from established, reputable suppliers, …See details»
Stanley M. Bergman to Retire as Henry Schein’s Chief Executive …
20 hours ago The Investor Relations website contains information about Henry Schein's business for stockholders, potential investors, and financial analysts.See details»
Schein Pharmaceutical, Inc Careers and Employment - Indeed
Feb 1, 2018 Find out what works well at Schein Pharmaceutical, Inc from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare …See details»
SCHEIN PHARMACEUTICAL MANAGEMENT WILL CONTINUE …
SCHEIN PHARMACEUTICAL MANAGEMENT WILL CONTINUE UNDER DIRECTION of current president, Martin Sperber, following the death of Chairman Jacob Schein on Nov. 4. Schein, …See details»